MediWound Ltd.
MDWD
$17.25
-$0.355-2.02%
NASDAQ
| 06/30/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -111.23% | -124.21% | -788.32% | -163.44% | |
| Total Depreciation and Amortization | 10.36% | 14.74% | 13.33% | 21.45% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 214.49% | 35.87% | 157.35% | 2,735.06% | |
| Change in Net Operating Assets | -261.84% | 240.12% | 83.98% | -147.13% | |
| Cash from Operations | -58.87% | 37.40% | 31.00% | -806.75% | |
| Capital Expenditure | 65.22% | 63.51% | -183.19% | 16.35% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 1.59% | -22.15% | 123.43% | 91.16% | |
| Cash from Investing | 72.41% | -3.98% | 110.91% | 76.03% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -35.05% | -18.63% | -36.31% | -37.85% | |
| Issuance of Common Stock | 654.95% | -- | -- | -98.02% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -31.22% | |
| Cash from Financing | 633.01% | -151.47% | 74.57% | -102.88% | |
| Foreign Exchange rate Adjustments | 113.33% | -99.47% | 87.50% | 73.59% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 66.52% | 3.59% | 97.19% | -141.93% | |